Uncovering negative results: Introducing an open access journal “Journal of Pharmaceutical Negative Results”

Abstract

Drug discovery nowadays is a highly innovative process
by which new drugs are discovered and/or designed. It
is expected that in the year 2010, at least 50% of all new
approved drugs will come from the biopharmaceutical
sector. The discovery and validation process is mostly
carried out by new innovative and medium-sized
companies. But, despite advances in technology and greater
understanding of biological systems, drug discovery is still
a lengthy process. Specialized drug discovery companies
need an ideal business climate, that is, political, economic
and social conditions, to be able to cope with the
entrepreneurial risks of drug development.